AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2024
May 10, 2024
34301_dirs_2024-05-10_5a47b10f-522c-4f6c-a5e4-9e3f5b47a6aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2024-05-08
Reporting Person: Lenk Robert P (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-08 | Common Stock | P | 4167 | $2.04 | Acquired | 29327 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-08 | Warrants (Right to buy) | $1.79 | A | 8334 | Acquired | Common Stock Warrants (8334) | Direct |
Footnotes
F1: The expiration date for 4,167 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,167 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.
F2: Half of the warrants are Series A warrants and the other half are Series B warrants.
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26
Director's Dealing
2026
Feb 27